Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine

Molecules. 2022 May 21;27(10):3311. doi: 10.3390/molecules27103311.

Abstract

Porphyrin ligands, showing a significant affinity for cancer cells, also have the ability to chelate metallic radioisotopes to form potential diagnostic radiopharmaceuticals. They can be applied in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) to evaluate metabolic changes in the human body for tumor diagnostics. The aim of this paper is to present a short overview of the main metallic radionuclides complexed by porphyrin ligands and used in these techniques. These chelation reactions are discussed in terms of the complexation conditions and kinetics and the complex stability.

Keywords: metallic radionuclides; porphyrins; positron emission tomography; single-photon emission computed tomography.

Publication types

  • Review

MeSH terms

  • Chelating Agents
  • Humans
  • Ligands
  • Molecular Imaging / methods
  • Nuclear Medicine*
  • Porphyrins*
  • Radioisotopes

Substances

  • Chelating Agents
  • Ligands
  • Porphyrins
  • Radioisotopes

Grants and funding

This research received no external funding.